Liminatus Pharma sets 1-for-50 reverse stock split to regain Nasdaq compliance
The split takes effect August 20, 2026, part of an effort to satisfy Nasdaq's minimum bid price rule after months of listing deficiency notices.
Liminatus Pharma, Inc. (Nasdaq: LIMN) said its board adopted a 1-for-50 reverse stock split of its common stock, approved by stockholders at the company's 2026 annual meeting held on August 3, 2026. The Reverse Stock Split will take effect at the close of trading on August 20, 2026, and the Company's Common Stock is expected to begin trading on a split-adjusted basis on The Nasdaq Capital Market under the Company's existing trading symbol "LIMN," at the market open on August 21, 2026.1
At the effective time, every 50 issued and outstanding shares will be automatically combined into one share, and if the split had been implemented as of July 2, 2026, total outstanding shares would have been reduced proportionately from 67,160,362 to approximately 1,343,208.1 No fractional shares will be issued; instead, fractional shares will be rounded up to the nearest whole share with no cash payment.1
The split follows a series of Nasdaq compliance notices. On November 19, 2025, the company received notices that it was no longer in compliance with Nasdaq's minimum Market Value of Listed Securities and Market Value of Publicly Held Shares rules, with 180 days, until May 18, 2026, to regain compliance.1 On January 15, 2026, Nasdaq also flagged noncompliance with the $1 minimum bid price rule, giving the company until July 14, 2026 to regain compliance.1
On July 31, 2026, a Nasdaq Hearings Panel decided to transfer the company to The Nasdaq Capital Market effective August 4, 2026, and granted an exception requiring the company to file a transfer application by August 7, 2026 and demonstrate a $1.00 closing bid price for ten consecutive trading days by August 28, 2026.1 On August 12, 2026, the Panel granted a brief extension to demonstrate compliance by September 3, 2026.1
The company said it expects that after the split takes effect, it will regain compliance with the bid price rule, though it cautioned there is no assurance it will do so within the prescribed time period.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.